RecruitingNCT06876610
Application of CfDNA Methylation Detection in Auxiliary Diagnosis of Breast Cancer
Sponsor
Geneplus-Beijing Co. Ltd.
Enrollment
200 participants
Start Date
Mar 15, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to construct an auxiliary diagnostic model for breast cancer by methylation markers. The study will collect blood and tissue samples from participants with breast cancer and benign disease for whole-genome methylation sequencing. It will screen methylation markers and develop a methylation auxiliary diagnosis model to distinguish between breast cancer and non-cancer.
Eligibility
Min Age: 30 YearsMax Age: 75 Years
Inclusion Criteria2
- With confirmed pathological diagnosis and molecular subtyping results
- Ability to provide a written informed consent
Exclusion Criteria11
- Patients with a history of or currently suffering from other malignancies
- Pregnant or planning to become pregnant female patients
- Patients who have received cancer treatment, including surgery, chemotherapy, radiotherapy, targeted therapy, and immunotherapy, before blood draw
- Patients with a history of blood transfusion within the past month
- Patients with a known history of allogeneic organ transplantation and allogeneic hematopoietic stem cell transplantation
- Patients with persistent fever or undergoing anti-inflammatory treatment within 14 days before blood draw
- Any other conditions that the researcher deems may make the patient unsuitable for inclusion in the study or may interfere with the completion of the study
- Patients in poor physical condition who are not suitable for blood draw
- Patients who cannot provide informed consent or refuse blood draw
- History of malignancies
- Current malignancies or precancerous lesions
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06876610
Related Trials
Breast Density Impact on Mammographic Screening for Breast Cancer Diagnosis
NCT074154991 location
AI-Enhanced Imaging in Population Breast Cancer Screening
NCT074114431 location
B.Brilliant Revelation Comparision Study
NCT070677881 location
A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients
NCT069342396 locations
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
NCT0262085211 locations